Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-828 vs Telmisartan in Hypertension
NCT01426100Phase 3Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Aug 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Levamlodipine in hypertension (HTN), sponsored by Chong Kun Dang Holdings. Started Aug 2011; status: completed.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01426100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426100.